Reference : A phase I trial of sunitinib, a tyrosine kinase inhibitor (TKI) combined with ionizing i...
Scientific journals : Article
Human health sciences : Oncology
http://hdl.handle.net/2268/40350
A phase I trial of sunitinib, a tyrosine kinase inhibitor (TKI) combined with ionizing irradiation in rectal cancer
English
Coucke, Philippe mailto [Université de Liège - ULg > > Radiothérapie >]
2009
Belgian Journal of Medical Oncology [=BJMO]
Ariez Medical Publishing
3
3
117
National
1784-7141
Amsterdam
Netherlands
Researchers ; Professionals ; Students ; General public ; Others
http://hdl.handle.net/2268/40350

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
A phase I trial of sunitinib, a tyrosine kinase inhibitor (TKI) combined with ionizing irradiation in rectal cancer.pdfNo commentaryPublisher postprint258.71 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.